What Makes a Customer of Choice: Are Pharma Companies & Suppliers Aligned?
Wednesday, March 19, 2025 • 10:00 AM – 11:00 AM • InterContinental Barclay, Grand Ballroom (2nd Floor)
Benchmark Your Company Against Industry Peers
Strong and mutually beneficial customer–supplier relations are always of importance, but they have taken on even greater significance as companies navigate unique challenges to assure supply of critical materials and services in a post-pandemic environment. While these developments have not changed the traditional customer–supplier relationship, they are making bio/pharma companies more aware of how their supplier relationships can impact their ability to deliver value to key stakeholders: patients and investors.
Gain valuable insights from an executive panel providing a “buy-and-sell-side view” on:
- What criteria do suppliers use in designating their “customers of choice” or “preferred customers”?
- In turn, what initiatives are bio/pharma companies taking to make themselves “customers of choice” or “preferred customers” at their suppliers?
- Are bio/pharma companies and suppliers aligned in what constitutes a “customers of choice” or “preferred customers” of their suppliers?
Plus, get the highlights of the key findings from an in-depth DCAT Research & Benchmarking study, What Makes a Customer of Choice: Are Pharma Companies & Suppliers Aligned, to be released in May 2025.
Price & Registration
DCAT Member Company Price: Complimentary
DCAT Week 2025 programs are exclusively available to registered DCAT Member Company employees. Confirm your company’s membership here or email DCATMembership@dcat.org.
Who Should Attend?
- Bio/pharmaceutical companies, including individuals with functional responsibility in sourcing, procurement, supply management and external manufacturing.
- CDMOs/CMOs and suppliers (raw materials and other inputs), including individuals engaged in business development, sales, marketing and operational functions in support of bio/pharmaceutical development and manufacturing.
- Other companies engaged in the business of bio/pharmaceutical development and manufacturing.
Attending DCAT Week Programs
All materials provided to registrants (including slides, reports, and presented information) are only for their reference. Registrants may not copy, photograph, or redistribute any materials, and they are responsible for any claim for violations of copyright or other intellectual property rights.